Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Companies 1/25
Result 613 decisions over 120 months
Reset filters
Minimum amount ? Share of their own holding ?
What the chief executive holds ?
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
7 Mar 2024
CVP, JAPAC
Sold on a plan
1,715
$156.03K
9.1%
4 Mar 2024
Director
Sold on a plan
29,350
$2.54M
86.7%
29 Feb 2024
CVP, Chief Financial Officer
Sold on a plan
7,255
$620.92K
27.6%
23 Feb 2024
Director indirect
Sold at will
3,058
$267.91K
4.4%
21 Feb 2024
CVP, TMTT
Sold at will
8,200
$711.27K
26.5%
15 Feb 2024
CVP, Critical Care
Sold at will
27,000
$2.31M
43.7%
13 Feb 2024
CVP, Critical Care
Sold at will
20,000
$1.73M
36.5%
13 Feb 2024
CVP,Strategy/Corp Development
Sold on a plan
11,000
$944.16K
21.8%
12 Feb 2024
SVP, Corporate Controller
Sold at will
12,210
$1.06M
48.3%
8 Feb 2024
Director
Sold at will
7,056
$609.99K
20.7%
5 Feb 2024
Director
Sold on a plan
29,350
$2.57M
86.7%
1 Feb 2024
CVP, Chief Financial Officer
Sold on a plan
7,255
$567.99K
27.4%
12 Jan 2024
CVP,Strategy/Corp Development
Sold on a plan
10,000
$756.70K
20.2%
5 Jan 2024
Director
Sold on a plan
29,350
$2.14M
86.7%
29 Dec 2023
CVP, Chief Financial Officer
Sold on a plan
14,510
$1.11M
43.0%
15 Dec 2023
CVP, TMTT
Sold at will
7,000
$547.72K
22.6%
13 Dec 2023
Director
Sold on a plan
29,350
$2.19M
86.7%
13 Dec 2023
Global President TAVR & Surg
Sold on a plan
8,658
$622.16K
3.9%
13 Dec 2023
CVP,Strategy/Corp Development
Sold on a plan
8,000
$574.88K
16.8%
6 Dec 2023
CVP, TMTT
Sold on a plan
3,500
$245.01K
12.8%
13 Nov 2023
Global President TAVR & Surg
Sold on a plan
8,660
$565.46K
3.9%
13 Nov 2023
CVP,Strategy/Corp Development
Sold on a plan
6,000
$391.78K
13.2%
3 Nov 2023
Director
Sold on a plan
29,350
$1.97M
86.7%
31 Oct 2023
CVP, Chief Financial Officer
Sold on a plan
7,255
$454.57K
27.4%
13 Oct 2023
Global President TAVR & Surg
Sold on a plan
8,660
$606.20K
3.9%
13 Oct 2023
CVP,Strategy/Corp Development
Sold on a plan
5,000
$349.91K
11.2%
10 Oct 2023
CVP, Critical Care
Sold on a plan
5,000
$363.40K
12.6%
3 Oct 2023
CVP, TMTT
Sold on a plan
8,500
$595.00K
26.2%
2 Oct 2023
Director
Sold on a plan
29,350
$2.02M
86.7%
29 Sep 2023
CVP, Chief Financial Officer
Sold on a plan
7,255
$504.53K
27.4%
14 Sep 2023
Global President TAVR & Surg
Sold on a plan
8,660
$637.62K
3.9%
14 Sep 2023
CVP,Strategy/Corp Development
Sold on a plan
4,500
$331.70K
10.2%
8 Sep 2023
CVP, Critical Care
Sold on a plan
5,000
$380.00K
12.6%
6 Sep 2023
CVP, TMTT
Sold on a plan
8,500
$646.61K
26.2%
5 Sep 2023
Director
Sold on a plan
29,350
$2.23M
86.7%
31 Aug 2023
CVP, Chief Financial Officer
Sold on a plan
7,255
$564.37K
27.4%
29 Aug 2023
CVP, TMTT
Sold at will
1,500
$115.04K
5.9%
14 Aug 2023
Global President TAVR & Surg
Sold on a plan
6,421
$509.19K
2.9%
14 Aug 2023
CVP,Strategy/Corp Development
Sold on a plan
4,500
$356.85K
10.2%
10 Aug 2023
Director
Sold at will
3,303
$260.51K
10.9%
9 Aug 2023
CVP, Critical Care
Sold on a plan
5,000
$393.19K
12.6%
7 Aug 2023
Director
Sold on a plan
29,350
$2.34M
35.1%
31 Jul 2023
CVP, Chief Financial Officer
Sold on a plan
7,255
$611.96K
27.4%
14 Jul 2023
Global President TAVR & Surg
Sold on a plan
8,660
$804.84K
3.9%
14 Jul 2023
CVP,Strategy/Corp Development
Sold on a plan
3,500
$325.28K
8.1%
10 Jul 2023
CVP, Critical Care
Sold on a plan
5,000
$452.60K
12.6%
5 Jul 2023
Director
Sold on a plan
29,350
$2.66M
35.1%
30 Jun 2023
CVP, Chief Financial Officer
Sold on a plan
7,255
$676.67K
27.4%
14 Jun 2023
Global President TAVR & Surg
Sold on a plan
8,660
$780.68K
3.9%
14 Jun 2023
CVP,Strategy/Corp Development
Sold on a plan
3,500
$314.20K
8.1%
Showing 101–150 of 613. ← Newer Page 3 of 13 Older →